BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2484311)

  • 21. Tumor vascular therapy with TNF: critical review on animal models.
    Hagen TL; Eggermont AM
    Methods Mol Med; 2004; 98():227-46. PubMed ID: 15064444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biotherapy of cancer].
    Subirá ML; Brugarolas A
    Rev Clin Esp; 1992 Jun; 191(2):102-8. PubMed ID: 1380172
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preclinical evaluation of anticancer drugs: a model remaining a model!].
    Lavelle F
    Bull Cancer; 1998 Oct; 85(10):837-42. PubMed ID: 9835860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
    Voskoglou-Nomikos T; Pater JL; Seymour L
    Clin Cancer Res; 2003 Sep; 9(11):4227-39. PubMed ID: 14519650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental animal models for the study of therapeutic approaches in renal cell carcinoma.
    Hillman GG; Droz JP; Haas GP
    In Vivo; 1994; 8(1):77-80. PubMed ID: 8054515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
    Hsieh CL; Chung LW
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytokines as immunotherapy in cancer].
    van der Schelling GP; Ijzermans JN; Marquet RL; Jeekel J
    Ned Tijdschr Geneeskd; 1992 Apr; 136(14):681-5. PubMed ID: 1373229
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of human colonic cancer models by surgical cecal implantation in nude mice].
    Pocard M; Middleton S; Northover J; Poupon MF
    Ann Chir; 1999; 53(3):227-32. PubMed ID: 10339865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
    Winograd B; Boven E; Lobbezoo MW; Pinedo HM
    In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of prostate cancer.
    Russell PJ; Voeks DJ
    Methods Mol Med; 2003; 81():89-112. PubMed ID: 12725117
    [No Abstract]   [Full Text] [Related]  

  • 31. Metastasis models for human tumors in athymic mice: useful models for drug development.
    Fine DL; Shoemaker R; Gazdar A; Mayo JG; Fodstad O; Boyd MR; Abbott BJ; Donovan PA
    Cancer Detect Prev Suppl; 1987; 1():291-9. PubMed ID: 3480056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of immunodeficient mice in metastasis research.
    Mitchell BS; Schumacher U
    Br J Biomed Sci; 1997 Dec; 54(4):278-86. PubMed ID: 9624739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of chondrosarcoma animal models for assessment of adjuvant therapy.
    Clark JC; Dass CR; Choong PF
    ANZ J Surg; 2009 May; 79(5):327-36. PubMed ID: 19566512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicine. Building better mouse models for studying cancer.
    Marx J
    Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of xenografts for the evaluation of tumor chemotherapy. Application to adjuvant chemotherapy].
    Duplan JF
    Bull Cancer; 1984; 71(4):292-6. PubMed ID: 6498344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokines and immunological monitoring.
    Kopp WC; Holmlund JT
    Cancer Chemother Biol Response Modif; 1996; 16():189-238. PubMed ID: 8639383
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice.
    Abe T; Tada M; Shinohara N; Okada F; Itoh T; Hamada J; Harabayashi T; Chen Q; Moriuchi T; Nonomura K
    Int J Urol; 2006 Jan; 13(1):47-57. PubMed ID: 16448432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokines and pancreatic cancer. Sensitivity of xenotransplants of predominantly pancreatic carcinomas to rIFN-gamma and rTFN-alpha in nude mice.
    Kühl JS; Klapdor R; Bahlo M; Franke N; Kunde C; Arps H; Dietel M
    Int J Pancreatol; 1989 Apr; 4(3):303-19. PubMed ID: 2503584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Systemic and regional administration of cytokines in oncology].
    Lejeune F
    Rev Med Suisse Romande; 1993 Jan; 113(1):11-2. PubMed ID: 7679521
    [No Abstract]   [Full Text] [Related]  

  • 40. Mouse orthotopic models for bladder cancer research.
    Chan E; Patel A; Heston W; Larchian W
    BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.